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Introduction
The complex congenital malformations are fre-
quently rare diseases. The rare diseases are infre-
quent and often little known pathological conditions
(1/2,000 live-born in the general population(1)). They
are often not diagnosed or diagnosed late with the
resulting negative consequences for the patient and
his/her family. The birth prevalence is high (2-4% of
all births). They are characterized by the presence of
health problems and/or functional deficits that
require multiple medical, psychological and social
support(2-6).
The Centers for rare diseases  have multidisci-
plinary teams that take care globally of patients with
rare pathologies. They must make diagnoses, orga-
nize clinical and psychomotor follow-up programs
and offer genetic counseling to the families. The
Centers must prepare an assistance plan for each
pathology (calendar of clinical and specialized
check-ups, rehabilitation program, introduction into
scholastic, social and work activities where possi-
ble), that involve doctors, structures and the families.
The Center staff should organize initiatives, plans
and protocols to protect patients with rare patholo-
gies, involving local pediatricians and organizing
seminars and meetings both with health personnel
and with the families and associations. 
There can be several etiological causes: envi-
ronmental causes, mendelian diseases, chromosomal
abnormalities, imprinted  anomalies.
Environmental causes
A complete and deep anamnestic evaluation of
patient history with special reference to neonatal age
when many risk factors (prematurity(7,8), connatal
infections(9,10), nosocomial infections(11-14), chemical
mediators(15,16), etc…) may play a role in determinig
outcome. 
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ABSTRACT
Complex congenital malformations, associated in 30% of cases with mental retardation, recognize different etiologies: envi-
ronmental causes, mendelian disease, chromosomal abnormalities, imprinted  anomalies. Frequently complex congenital disorders
are rare diseases. Rare diseases are infrequent pathological conditions (prevalence in the general population of less than 1/2.000
live births1), and often poorly understood. Because of their rarity these morbid conditions often either go undiagnosed or are diag-
nosed late with a negative impact for both the affected person and the family. The birth prevalence is high (2-4% of all births). The
diagnosis is essential to program complex and integrated care interventions (follow-up programs aimed at early detection of any
disease associated with different syndromes) and to carry out  proper genetic family counseling (risk of recurrence, prenatal diag-
nosis, detection of heterozygotes etc).
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Connatal infections
Viral (citomegalovirus, varicella-zoster virus,
herpes simplex virus 1 (HSV-1) e 2 (HSV-2), rubel-
la virus, parvovirus B19 (B19V), HIV, HBV, HCV)
and toxoplasma connatal infections may be trans-
mitted from mother to child at different times, rang-
ing from in utero transmission, that occur during
pregnancy, perinatal transmission, that takes place
during delive-ry and postnatal transmission, that is
often the consequence of breastfeeding. They are
potentially harmful to the fetus or the newborn
child since they may result in miscarriage, fetal
death, congenital anomalies, intrauterine growth
restriction or severe neonatal disease.
Amniotic band sequence (ADAM complex)
Amniotic band sequence is a congenital disor-
der due to the entrapment of parts of the fetus (usu-
ally a limb or digits) in fibrous amniotic bands dur-
ing pregnancy (constriction rings around the digits,
arms and legs; swelling of the extremities distal to
the point of constriction (congenital lymphedema);
amputation of digits, arms and legs (congenital
amputation)(17).
Prematurity
Infants born before 37 weeks gestation are con-
sidered premature and may be at risk for complica-
tions even later in life (cerebral palsy, sight prob-
lems, impaired cognitive skills, hearing defects,
behavioral and psychological problems etc.)(18-27).
Drugs during pregnancy
It is better to avoid the use of drugs during
pregnancy unless they are really necessary, taking
into consideration the potential risks to the fetus
(tab.1)(28).
Mendelian disesases
Autosomal recessive disorders
In an autosomal recessive disorder two copies
of an abnormal gene must be present so that the dis-
ease or trait may develop. Among the autosomal
recessive disorders there are congenital metabolic
diseases that occur with heterogeneous clinical signs
(growth retardation, mental retardation, birth defects
or deformities, neurological disorders, convulsions,
gastrointestinal disorders etc.), skeletal dysplasias
(spondylocostal dysostosis, Jeune asphyxiating tho-
racic dystrophy, Ellis van Creveld syndrome etc.)(29,30)
and multiple malformation syndromes (Klipper-Feil
syndrome, Alport syndrome etc.).
DRUG TERATOGENIC EFFECT
Aminopterin, methotrexate CNS and limb malformations
Angiotensin-converting
enzyme inhibitors
Prolonged renal failure in neonates,
decreased skull ossification,
renal tubular dysgenesis
Anticholinergic drugs Neonatal meconium ileus
Antithyroid drugs
(propylthiouracil and
methimazole) 
Fetal and neonatal goiter and
hypothyroidism,
aplasia cutis (with methimazole)
Carbamazepine Neural-tube defects 
Cyclophosphamide CNS malformationssecondary cancer
Danazol and other
androgenic drugs Masculinization of female fetuses
Diethylstilbestrol
Vaginal carcinoma and other
genitourinary defects in female
and male offspring 
Hypoglycemic drugs Neonatal hypoglycemia 
Lithium Ebstein’s anomaly 
Misoprostol Moebius sequence
Nonsteroidal
antiinflammatory drugs
Constriction of the ductus
arteriosus, necrotizing
Enterocolitis 
Paramethadione Facial and CNS defects
Phenytoin Growth retardation,CNS deficits
Psychoactive drugs
(e.g., barbiturates, opioids,
and benzodiazepines)
Neonatal withdrawal syndrome
when drug
is taken in late pregnancy
Systemic retinoids
(isotretinoin and etretinate) 
CNS, craniofacial, cardiovascular,
and other defects
Tetracycline Anomalies of teeth and bone
Thalidomide Limb-shortening defects,internal-organ defects
Trimethadione Facial and CNS defects
Valproic acid Neural-tube defects
Warfarin Skeletal and CNS defects,Dandy-Walker syndrome
Table 1: Drugs with proven teratogenic effects in
humans.
(modified from Koren G et al, N Engl J Med 1998, 338
(16):338(16):1128-37)
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Autosomal dominant disorders
Dominance in genetics is a relationship
between alleles of a gene, in which one allele masks
the expression (phenotype) of another at the same
locus. Autosomal dominant diseases are character-
ized by variable clinical expressivity and penetrance
and can be transmitted by an affected parent, or more
frequently they are related to new mutations. Several
complex disabilities are transmitted with an autoso-
mal dominant trait (Trichorhinophalangeal syn-
drome, achondroplasia, Sotos syndrome, Rubinstein
Taybi syndrome, etc..)(31,32).
X-linked disorders
An X-linked character is a character located on
the sex chromosome X. Two X chromosomes are
present in the individual female (XX) and 1 in the
male (XY). In the female only one X chromosome is
active, since the other is inactivated (lyonization).
Among the complex X-linked disorders we can
include the Fragile X syndrome, Rett syndrome,
anhidrotic ectodermal dysplasia(33,34) etc.
Chromosomal abnormalities
About 1 in 150 babies are born with a chromo-
somal abnormality. These abnormalities are caused
by errors in the number or structure of chromosomes.
Many children with a chromosomal abnormality
have mental and/or physical birth defects. Some
chromosomal abnormalities result in miscarriage or
stillbirth. Among the most frequent chromosomal
pathologies there is the Down Syndrome, but in the
past few years, the introduction of array-CGH (com-
parative genomic hybridization) has made the analy-
sis of the human genome and is quickly revolutioniz-
ing the definition of molecular diagnostics in patients
with “chromosomal” phenotype (intellectual disabili-
ty, dysmorphic features, congenital anomalies) and
normal karyotype (16p11.2 syndrome. 22q11.2 syn-
drome, 17q21.31 syndrome etc.)(35-40).
Imprinted anomalies
We inherit two copies of every autosomal gene
from our parents, one from our mother and the other
from our father. Both copies are functional in most of
the genes but, in a small subset one copy is turned
off in a parent-of-origin dependent manner. These
genes are called ‘imprinted’ because one copy of the
gene was epigenetically marked or imprinted in
either the egg or the sperm. Thus, the allelic expres-
sion of an imprinted gene depends upon whether it
resided in a male or female the previous generation.
Imprinted expression can also vary between tissues,
developmental stages and species(41).
Imprinted genes are susceptibility targets for
various human pathologies since their functional
haploid state enables a single genomic or epigenomic
change to dysregulate their function causing poten-
tially harmful health effects. Imprinting anomalies
often appear as developmental and neurological dis-
orders when they occur during early development,
and as cancer when they develop later in life.
Specifically, imprinting disorders have been linked to
Angelman and Prader-Willi Syndromes, Alzheimer
disease, autism, bipolar disorder, diabetes, male sex-
ual orientation, obesity, and schizophrenia(42).
Follow-up
Complex congenital disorders have particular
characteristics: chronic nature (the lack of effective
treatment or, in the best cases, life-long treatment),
rarity (difficult and often delayed diagnosis, lack of
guide lines), co-morbidity (various associated
pathologies requiring multi-specialistic team). The
follow-up programs must foresee, on one hand, the
main developmental areas (hearing and psychomo-
tor) and, on the other hand, the precocious diagnosis
of all the most frequently associated pathologies
(both congenital and acquired).
According to the suggestions of the Italian
Society of Pediatric Genetic Diseases and Congenital
Dysabilities, personalized interventions (individual-
ized treatment plan) are foreseen for each patient
with complex congenital disorders:
• global aspects since children with genetic
pathologies have the same rights and health needs as
other children (vaccinations, precocious prevention
measures),
• multidisciplinary aspects since they have
problems of various types and nature for which
plurispecialist competences (eg. pediatric cardiology,
surgery and immune-hematology, child neuropsychi-
atry rehabilitation, etc) and multidisciplinary ones
(eg. pedagogy, psychology, social assistance, etc.)
are necessary,
• integrated aspects since the treatment of these
pathologies is medical-clinical and must be undertak-
en in specialized hospitals and on the territory but
also of social, rehabilitative, formative and educative
interventions,
• participation of medical staff, family members
and patients (when possible), because the definition
of the priorities and of the meaningful objectives in
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the course of time cannot be kept apart from a con-
tinuous sharing and negotiation with the family and
among the operators and services involved.
Complex congenital disabilities are often rare
diseases. If they are often not diagnosed or the diag-
nosis is delayed the resulting consequences may be
negative for the patient and the family. A diagnosis is
essential to plan a multispecialistic and multidiscipli-
nary follow-up program for the patient and also to
provide genetic counseling to the family.
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